THC

Tetrahydrocannabinol (THC) is the principal psychoactive constituent of the cannabis plant and the best known of the cannabinoids, a class of compounds built from a blend of terpenoid and polyketide chemistry. The molecule exists in several isomeric forms; the one responsible for most of the plant's activity is delta-9-tetrahydrocannabinol, though related isomers such as delta-8 also occur ^[1][3]. In pure form it is a lipophilic, oily substance that dissolves poorly in water, a property that shapes how it is absorbed and distributed in the body ^[1].

The compound was first isolated and its structure determined in 1964 by the Israeli chemists Raphael Mechoulam and Yehiel Gaoni, a landmark that opened the modern study of cannabinoids ^[2]. Earlier work in the 1940s had characterized related constituents of the plant, but it was the 1964 report that established the identity of the active principle ^[2][3]. That discovery ultimately led to recognition of the body's own endocannabinoid system, on which THC acts ^[3].

Recreationally, THC produces euphoria, relaxation, heightened sensory experience, and appetite stimulation, along with possible short-term impairment of memory and coordination and, at higher exposures, anxiety or perceptual disturbances ^[1][3]. Medically, a synthetic form marketed as dronabinol is approved to treat nausea and vomiting caused by chemotherapy and to stimulate appetite in wasting linked to HIV/AIDS, while a standardized cannabis extract combining THC with cannabidiol is used for spasticity in multiple sclerosis ^[1][3].

When inhaled, THC enters the bloodstream within seconds and its effects peak quickly, whereas oral intake produces a slower, delayed onset because of extensive first-pass metabolism in the liver ^[1]. It is broken down largely by cytochrome P450 enzymes into metabolites including the active 11-hydroxy-THC and the inactive carboxy-THC that is measured in drug testing ^[1]. Legally, THC and cannabis are controlled internationally under United Nations drug conventions, and national status varies widely, ranging from prohibition to regulated medical and adult recreational use ^[1][3]. It is encountered as herbal cannabis, concentrated extracts, edibles, and standardized pharmaceutical preparations ^[1].

THC is the primary psychoactive cannabinoid; it causes intoxication and impairs coordination, reaction time, memory, and driving. Risks include anxiety, paranoia, and, particularly at high doses or in vulnerable individuals, psychosis, along with a faster heart rate and, with heavy regular use, dependence and cannabinoid hyperemesis syndrome. It can worsen or precipitate psychiatric conditions, should be avoided in pregnancy, and is more impairing when combined with alcohol or other sedatives.

Delta-9-tetrahydrocannabinol was first isolated and its structure elucidated in 1964 by Raphael Mechoulam and Yechiel Gaoni at the Weizmann Institute of Science in Israel, a landmark that identified the principal psychoactive constituent of cannabis after decades of uncertainty about the plant's active chemistry. Mechoulam's group went on to synthesize THC and characterize related cannabinoids, laying the groundwork for the field.

The receptors THC acts upon, CB1 and CB2, were identified in the late 1980s and early 1990s, and the discovery of the body's own endocannabinoids, such as anandamide, soon followed, revealing an entire endocannabinoid signaling system. A synthetic form of THC, dronabinol, was approved by the United States Food and Drug Administration in 1985 for chemotherapy-induced nausea and later for appetite stimulation. THC and cannabis-derived products have since become the focus of extensive medical research and evolving legal frameworks around the world.

THC is among the most recognized and studied natural compounds in the world, celebrated for the discovery that opened up the endocannabinoid system, one of the most consequential findings in modern pharmacology. In medicine it has an established role: the synthetic form dronabinol is an approved therapy for chemotherapy-induced nausea and for appetite loss, and THC-containing products are used by many patients for pain, spasticity, and other symptoms.

Its influence on mood, perception, appetite, and pain has made it a subject of intense scientific and cultural interest. Honesty about its profile is important, however: THC is psychoactive and impairing, tolerance develops with repeated use, and it can provoke anxiety or, in susceptible individuals, other adverse psychological effects, while legal status varies widely by jurisdiction. Its recognized therapeutic uses coexist with genuine cautions that any responsible discussion should acknowledge.